China Universal Asset Management »

Apogee Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $321k 8.1k 39.73
2025-06-30 $619k 14k 43.43
2025-03-31 $337k 9.0k 37.36
2024-12-31 $433k 9.5k 45.30
2024-09-30 $508k 8.7k 58.74
2024-06-30 $208k 5.3k 39.35
2024-03-31 $475k 7.2k 66.45
2023-12-31 $155k 5.6k 27.94

More positions owned by China Universal Asset Management

Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Alphabet Inc-cl A Common Stock (GOOGL)
Meta Platforms Inc-class A Common Stock (META)
Netflix Common Stock (NFLX)
Tesla Common Stock (TSLA)
Amgen Common Stock (AMGN)
Gilead Sciences Common Stock (GILD)
Vertex Pharmaceuticals Common Stock (VRTX)
Alphabet Inc-cl C Common Stock (GOOG)
Palantir Technologies Inc-a Common Stock (PLTR)
Applovin Corp-class A Common Stock (APP)

View all positions for China Universal Asset Management

Top funds holding Apogee Therapeutics

VR Adviser
FMR
Wellington Management Company
Rtw Investments
BlackRock
Vanguard Group
Driehaus Capital Management
Fairmount Funds Management
State Street Corporation
Paradigm Biocapital Advisors
Braidwell
Alliancebernstein
Perceptive Advisors
Citadel Advisors
Affinity Asset Advisors

View all funds holding Apogee Therapeutics